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Purpose: Develop an evidence-based decision-support 
framework for optimizing the location of Radium 223 (Ra) 
treatment facilities based on different metrics of geographic 
access. 
Methods and Materials: Residence at death and death date for 
all patients who died of prostate cancer in British Columbia 
between 2009 and 2014 were obtained from a prospectively 
maintained population-based registry. Patients who died of 
prostate cancer were considered potentially eligible for Ra 
treatment prior to death, assuming that they would go through 
a phase of symptoms from bone metastases. Forty-percent of 
patients in the province are known to receive palliative 
radiotherapy to bone prior to death from prostate cancer. Two 
metrics of geographic access were defined: average travel time 
to a treatment facility (ATT) and percentage of patients residing 
within 90 minutes travel to a treatment facility (C90). At the 
time of analysis, three nuclear medicine facilities were providing 
Ra (Vancouver, Victoria and Kelowna). All 22 other licensed 
nuclear medical facilities in the province were considered as 
feasible new locations for Ra treatment. Travel time from each 
patient’s residence to every facility was calculated using 
Microsoft MapPoint. An integer programming model was 
developed to find the facility locations that optimize ATT and 
C90. C90 was considered primary metric as ATT tends to 
overweight a small number of cases with very long travel times. 
Results: 3194 patients met eligibility criteria. Several scenarios 
seeking to improve geographic access by choosing different 
locations for Ra treatment were run. The first group of scenarios 
considered the existing locations and tested the addition of new 
locations from the nuclear medical facilities. Prior to death, 67% 
of patients lived within 90 minutes of one of the three centres 
currently providing Ra. C90 increased to 75%, 79%, and 82% when 
one, two and three additional facilities were added. ATT 
decreased from 156 minutes to 89, 79 and 70 minutes 
respectively. The additional facilities (mid-Vancouver Island, 
Kamloops and eastern Fraser Valley successively) were in areas 
with medium-high population density and long distances to the 
existing Ra facilities. To reach a C90 of 90%, a total of seven 
additional facilities would have to be opened. A second group of 
scenarios assumed a “greenfield” setting with no pre-existing 
facilities. Resulting facility locations differed from the existing 
locations and improved C90 to 70%, 78%, 82% and 85% with three, 
four, five and six Ra treatment facilities. 
Conclusions: Geographic access is one of the important factors 
to consider when deciding the location of treatment facilities. 
By measuring geographic access and determining optimal 
location of new facilities, the proposed framework provides a 
data-driven approach to quantitatively evaluate the 
configuration of a treatment delivery system. This framework 
can be expanded to include other clinical, operational and 
political considerations. 
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Purpose:  With increasing incidence and prevalence of cancer in 
Canada and beyond, the use of radiation therapy (RT) for both 
curative and palliative intents will continue to increase. 
Combined with the unprecedented pace of technological 
innovation and increasing complexity of care, the RT system 
must find new models of care to rethink the distribution of work 
and the skill sets required to do this work. In Ontario, the Clinical 
Specialist Radiation Therapy (CSRT) Project was created to 
ascertain if advanced practice radiation therapists (APRT) could 
add effectiveness and efficiency to the already burdened system 
in a value-added way. Since 2004, the project team has 
developed, implemented and evaluated the APRT role in a 
variety of clinical settings. 
Methods and Materials: After a period of time allotted to allow 
the pilot APRTs to acquire and prove competence in activities 
specific to their particular positions, mixed methods were used 
to test the impact of redistributing workload between APRTs and 
radiation oncologists (RO) under the headings of: 1) Quantity - 
ability to increase capacity at point of entry to the system 
(direct) and within the care pathway (indirect); 2) Quality - 
improvement in provision of patient care or addition of new 
services to improve the patient experience and/or satisfaction; 
and 3) Innovation and Knowledge Translation – the volume of 
research and innovation activities that include or are being led 
by APRTs. 
Results: In the 2014-2015 year, there were 24 CSRT “active” 
positions in place, with 21 of them being considered permanent 
full-time (CCO, 2015). Under the heading of Quantity, many 
positive direct and indirect impacts have been reported with the 
addition of CSRTs including: an increase in the number of new 
patients seen in consult (direct) and the number of RO hours 
saved (indirect). The reported number of additional patients 
seen was as high as 28 new patients per month (33% increase; 
average: 20%) and the reported number of RO hours saved were 
as high as 50 hours per month (average: 12.5 hours) which, at its 
maximum, represents a significant amount of ROs’ time 
allocated to clinical work and patient care (CCO, 2015).  
Conclusions: The CSRT-driven model of care can provide 
significant added value to the existing RT system by adding 
capacity for an increased number of patients to enter the system 
and for ROs to focus on more complex activities in their scope. 
It is suggested that this model should be considered a viable 
option for managing the pressures of the changing landscape in 
RT in Canada. 
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PATIENT EXPERIENCE SURVEY OF EARLY-STAGE BREAST CANCER 
PATIENTS UNDERGOING WHOLE BREAST RADIOTHERAPY  
Grace Lee1, Robert Dinniwell2, Anthony Fyles2, Tatiana Conrad2, 
Kathy Han2, Wilfred Levin2, Fei-Fei Liu2, Susanne Lofgren1, 
Alexandra Koch-Fitsialos1, Gerald Devins2, Nora Emad2, Bethany 
Pitcher1, Tony Panzarella1, Anne Koch2 
1Princess Margaret Cancer Centre, Toronto, ON 
2University of Toronto, Toronto, ON 
Purpose: Adjuvant breast radiotherapy (RT) is a standard 
treatment option in women with early-stage breast cancer 
following lumpectomy. Timeliness of RT treatment can impact 
patient satisfaction. The objectives of this study are to assess: 
1) patient satisfaction of their whole breast RT; 2) patient
preference for timing of RT start after CT simulation (CTSim); 
and 3) factors that influence patient stress and quality of life. 
Methods and Materials: Women undergoing whole breast RT 
were given a survey before RT treatment and at treatment 
completion. Patients were offered treatment either through the 
conventional process (ConvProcess), where RT starts typically 
within 1-2 weeks of CTSim, or the QuickStart (QS) process, where 
RT starts one day after CTSim. The pre-treatment (PRE-Tx) 
survey included questions to understand the social impact of RT, 
and the post-treatment (POST-Tx) survey included questions 
relating to social climate and patient satisfaction. Questions 
relating to RT start preference, stress (Perceived Stress Scale 
[PSS]) and quality of life (Illness Intrusiveness Ratings Scale 
[IIRS]), were assessed both at PRE-Tx and POST-Tx. An analysis 
of covariance was used to determine if the RT process impacted 
PSS and IIRS, and t-tests were used as a secondary analysis. 
Fisher’s Exact test was used where appropriate. 
Results: Ninety-six patients completed the PRE-Tx survey and 88 
completed both surveys (QS process n = 28; ConvProcess n = 60). 
All patients indicated they had a positive experience with the RT 
